$153.32
3.132.08%
마지막 업데이트: Oct 20, 3:09 PM
$152.10
1.901.26%
Benzinga
Benzinga
Benzinga
화요일, 10월 20
Benzinga
© 2026 Benzinga | All Rights Reserved
Novartis (NVS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.16 | $2.07 | $2.00 | $2.29 |
| Actual | $2.41 | $1.99 | $2.03 | $2.25 |
| Surprise | +11.6% | -3.86% | +1.50% | -1.75% |
| Revenue | ||||
| Estimate | $14.12B | $13.50B | $13.93B | $13.87B |
| Actual | $14.41B | $13.11B | $13.34B | $13.91B |
| Surprise | +2.01% | -2.84% | -4.24% | +0.30% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.24 | $2.22 | $2.29 | $2.54 |
| Revenue | ||||
| Consensus | $14.60B | $14.94B | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Jul 21, 2026 | $2.41 | $2.16 | 11.6 % |
| Q1 | Apr 28, 2026 | $1.99 | $2.07 | -3.86 % |
| Q4 | Feb 4, 2026 | $2.03 | $2.00 | 1.50 % |
| Q3 | Oct 28, 2025 | $2.25 | $2.29 | -1.75 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Jul 21, 2026 | $14.41B | $14.12B | 2.01 % |
| Q1 | Apr 28, 2026 | $13.11B | $13.50B | -2.84 % |
| Q4 | Feb 4, 2026 | $13.34B | $13.93B | -4.24 % |
| Q3 | Oct 28, 2025 | $13.91B | $13.87B | 0.30 % |